Vimarsana
Biggest News Aggregation in the World

Page 7 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Analyst Today - Breaking & Trending Today

Welcome To IANS Live - LatestNews - China to launch world's first oral insulin for Type-2 diabetes: Report - Vimarsana News

Welcome To IANS Live - LatestNews - China to launch world's first oral insulin for Type-2 diabetes: Report

After successfully completing Phase III trials of oral insulin, China's Hefei Tianhui Biotechnology (HTIT) submitted a marketing authorisation application (MAA) to the country's National Medical Products Administration.Oram

Astellas to accelerate ocular disease therapies via $5.9b acquisition - Vimarsana News

Astellas to accelerate ocular disease therapies via $5.9b acquisition

A $5.9 billion acquisition of biotech Iveric Bio by Astellas is set to accelerate development of treatments for blinding retinal diseases.

WHOs new Covid update on vax threaten demand, revenues, says report - Vimarsana News

WHOs new Covid update on vax threaten demand, revenues, says report

New Delhi, April 10: The recent update on Covid-19 vaccine and booster dose by the World Health Organization (WHO) can lead to reduction in global demand and revenue for vaccines against the deadly infectious disease, according to a report on Monday.

WHO's new Covid update on vax threaten demand, revenues, says report - Vimarsana News

WHO's new Covid update on vax threaten demand, revenues, says report

The recent update on Covid-19 vaccine and booster dose by the World Health Organization (WHO) can lead to reduction in global demand and revenue for vaccines against the deadly infectious disease, according to a report on Monday.The WHO ...

GlobalData : Alzheimer's drug Leqembi will generate $12.9 billion in sales by 2028, forecasts GlobalData - Vimarsana News

GlobalData : Alzheimer's drug Leqembi will generate $12.9 billion in sales by 2028, forecasts GlobalData

05 Apr, 2023 Alzheimer's drug Leqembi will generate $12.9 billion in sales by 2028, forecasts GlobalData Share Print page ... | April 5, 2023